SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-015646
Filing Date
2016-03-30
Accepted
2016-03-30 16:06:27
Documents
97
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cbyl-10k_20151231.htm 10-K 3318328
2 EX-23.1 cbyl-ex231_684.htm EX-23.1 2071
3 EX-31.1 cbyl-ex311_6.htm EX-31.1 18205
4 EX-31.2 cbyl-ex312_7.htm EX-31.2 18083
5 EX-32.1 cbyl-ex321_8.htm EX-32.1 14352
6 GRAPHIC gr3fdkhilqwe000002.jpg GRAPHIC 19621
7 GRAPHIC gr3fdkhilqwe000001.jpg GRAPHIC 8752
  Complete submission text file 0001564590-16-015646.txt   11496877

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cbyl-20151231.xml EX-101.INS 2546648
9 XBRL TAXONOMY EXTENSION SCHEMA cbyl-20151231.xsd EX-101.SCH 77183
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbyl-20151231_cal.xml EX-101.CAL 56706
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbyl-20151231_def.xml EX-101.DEF 278251
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbyl-20151231_lab.xml EX-101.LAB 572320
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbyl-20151231_pre.xml EX-101.PRE 470733
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36830 | Film No.: 161539630
SIC: 2834 Pharmaceutical Preparations